October 6 University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Giza Egypt (1996)

Organization Overview

First Clinical Trial
2009
NCT01113528
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

6th october university | Ahmed Essam | Department of Anesthesia and I.C.U. faculty of Medicine October six university, Egypt | Emad Eldin Mohamed | Faculty of Physical Therapy, October 6 University | Lama Saad El-Din Mahmoud | lecturer , department of Neuromuscular Disorders and its surgery, faculty of physical therapy O6U physical therapy | Lecturer,Department of physical therapy for Neuromuscular Disorders & its surgery / Faculty of physical therapy/ October 6 university | October 6 University | rabab ahmed mohamed | Reham Lotfy Aggour

Active Ingredients

Drugs in Phase 4 Trials (7)

hirudin (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

ivermectin (stromectol) (1 trial)

lopinavir (Kaletra) (2 trials)

remdesivir (Veklury) (2 trials)

ritonavir (Norvir) (2 trials)

tocilizumab (actemra) (1 trial)

Drugs in Phase 3 Trials (10)

canagliflozin (invokana) (1 trial)

carvedilol (coreg) (2 trials)

colistin (1 trial)

curcumin (2 trials)

dapagliflozin (farxiga) (1 trial)

empagliflozin (jardiance) (1 trial)

metformin (glucophage) (1 trial)

ramipril (altace) (1 trial)

spironolactone (aldactone) (1 trial)

vildagliptin (1 trial)

Drugs in Phase 2 Trials (19)

acetaminophen (tylenol) (1 trial)

acetylsalicylic acid (aspirin) (1 trial)

atorvastatin (lipitor) (1 trial)

bupivacaine (Exparel) (1 trial)

celecoxib (celebrex) (1 trial)

dexmedetomidine (precedex) (1 trial)

fexofenadine (allegra) (1 trial)

furosemide (lasix) (1 trial)

icosapent ethyl (vascepa) (3 trials)

itropride (1 trial)

niacin (1 trial)

olive (1 trial)

omega-3 fatty acids (Omacor) (1 trial)

porcine brain-derived peptide preparation (cerebrolysin) (1 trial)

prednisolone (hydeltra) (1 trial)

prednisone (meticorten) (1 trial)

pregabalin (lyrica) (1 trial)

rebamipide (1 trial)

trimetazidine (1 trial)

Drugs in Phase 1 Trials (7)

erythromycin (ilosone) (1 trial)

fentanyl (Innovar) (1 trial)

ketamine (ketalar) (2 trials)

metronidazole (flagyl) (1 trial)

ozonated oil (1 trial)

propofol (diprivan) (1 trial)

ropivacaine (naropin) (1 trial)

Drugs in Other Trials (3)

cetylpyridinium chloride (1 trial)

lidocaine (xylocaine) (1 trial)

linezolid (zyvox) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Periodontitis (Phase 2)

Hematoma (Phase 4)

Kidney Diseases (Phase 2)

Lichen Planus (Phase 2)

Lichen Planus, Oral (Phase 2)

Oral Ulcer (Phase 2)

Periodontal Diseases (Phase 2)

Periodontitis (Phase 2)

Stomatitis (Phase 2)

Stomatitis, Aphthous (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 31
  • # of Trial APIs: 46